These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 23065740)

  • 1. Carbon monoxide-treated dendritic cells decrease β1-integrin induction on CD8⁺ T cells and protect from type 1 diabetes.
    Simon T; Pogu S; Tardif V; Rigaud K; Rémy S; Piaggio E; Bach JM; Anegon I; Blancou P
    Eur J Immunol; 2013 Jan; 43(1):209-18. PubMed ID: 23065740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerogenic dendritic cells impede priming of naïve CD8⁺ T cells and deplete memory CD8⁺ T cells.
    Kleijwegt FS; Jansen DT; Teeler J; Joosten AM; Laban S; Nikolic T; Roep BO
    Eur J Immunol; 2013 Jan; 43(1):85-92. PubMed ID: 23042025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes.
    Pinkse GG; Tysma OH; Bergen CA; Kester MG; Ossendorp F; van Veelen PA; Keymeulen B; Pipeleers D; Drijfhout JW; Roep BO
    Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18425-30. PubMed ID: 16339897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-10-conditioned dendritic cells prevent autoimmune diabetes in NOD and humanized HLA-DQ8/RIP-B7.1 mice.
    Tai N; Yasuda H; Xiang Y; Zhang L; Rodriguez-Pinto D; Yokono K; Sherwin R; Wong FS; Nagata M; Wen L
    Clin Immunol; 2011 Jun; 139(3):336-49. PubMed ID: 21458378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exposure to IL-15 and IL-21 enables autoreactive CD8 T cells to respond to weak antigens and cause disease in a mouse model of autoimmune diabetes.
    Ramanathan S; Dubois S; Chen XL; Leblanc C; Ohashi PS; Ilangumaran S
    J Immunol; 2011 May; 186(9):5131-41. PubMed ID: 21430227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cells expressing BTLA induces CD8+ T cell tolerance and attenuates the severity of diabetes.
    Li S; Zhang M; Xiang F; Zhao J; Jiang C; Zhu J
    Vaccine; 2011 Oct; 29(44):7747-51. PubMed ID: 21827810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mimovirus encoding ChgA
    Sun H; Han X; Yan X; Xu J; Huang Q; Meng F; Zhang H; Li S
    Cell Immunol; 2017 Oct; 320():56-61. PubMed ID: 28916112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice.
    Pang S; Zhang L; Wang H; Yi Z; Li L; Gao L; Zhao J; Tisch R; Katz JD; Wang B
    Eur J Immunol; 2009 Oct; 39(10):2716-24. PubMed ID: 19658094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8+ T cells in type 1 diabetes.
    Tsai S; Shameli A; Santamaria P
    Adv Immunol; 2008; 100():79-124. PubMed ID: 19111164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
    Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
    Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects and regulation of autoreactive CD8+ T cells in a transgenic mouse model of autoimmune hepatitis.
    Zierden M; Kühnen E; Odenthal M; Dienes HP
    Gastroenterology; 2010 Sep; 139(3):975-86, 986.e1-3. PubMed ID: 20639127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotargeting of insulin reactive CD8 T cells to prevent diabetes.
    Scott GS; Fishman S; Khai Siew L; Margalit A; Chapman S; Chervonsky AV; Wen L; Gross G; Wong FS
    J Autoimmun; 2010 Dec; 35(4):390-7. PubMed ID: 20850948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
    Gallichan WS; Balasa B; Davies JD; Sarvetnick N
    J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerogenic dendritic cells induce antigen-specific hyporesponsiveness in insulin- and glutamic acid decarboxylase 65-autoreactive T lymphocytes from type 1 diabetic patients.
    Segovia-Gamboa N; Rodríguez-Arellano ME; Rangel-Cruz R; Sánchez-Díaz M; Ramírez-Reyes JC; Faradji R; González-Domínguez É; Sánchez-Torres C
    Clin Immunol; 2014 Sep; 154(1):72-83. PubMed ID: 24993292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of costimulatory ligand CD70 on steady-state dendritic cells breaks CD8+ T cell tolerance and permits effective immunity.
    Keller AM; Schildknecht A; Xiao Y; van den Broek M; Borst J
    Immunity; 2008 Dec; 29(6):934-46. PubMed ID: 19062317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TLR9 blockade inhibits activation of diabetogenic CD8+ T cells and delays autoimmune diabetes.
    Zhang Y; Lee AS; Shameli A; Geng X; Finegood D; Santamaria P; Dutz JP
    J Immunol; 2010 May; 184(10):5645-53. PubMed ID: 20393135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic expression of single-chain anti-CTLA-4 Fv on beta cells protects nonobese diabetic mice from autoimmune diabetes.
    Shieh SJ; Chou FC; Yu PN; Lin WC; Chang DM; Roffler SR; Sytwu HK
    J Immunol; 2009 Aug; 183(4):2277-85. PubMed ID: 19635924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective delivery of beta cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8+ T cells in NOD mice.
    Mukhopadhaya A; Hanafusa T; Jarchum I; Chen YG; Iwai Y; Serreze DV; Steinman RM; Tarbell KV; DiLorenzo TP
    Proc Natl Acad Sci U S A; 2008 Apr; 105(17):6374-9. PubMed ID: 18430797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-Galactosylceramide ameliorates autoimmune diabetes in non-obese diabetic mice through a suppressive effect mediated by CD8+ T cells.
    Chuang YP; Lin YC; Sytwu HK
    Immunol Lett; 2011 Jul; 138(1):54-62. PubMed ID: 21392534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Islet beta-cell-specific T cells can use different homing mechanisms to infiltrate and destroy pancreatic islets.
    Hänninen A; Nurmela R; Maksimow M; Heino J; Jalkanen S; Kurts C
    Am J Pathol; 2007 Jan; 170(1):240-50. PubMed ID: 17200197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.